Cardiac sympathetic hyperactivity in a patient with Guillain-Barré syndrome: An analysis using cardiac [123I] metaiodobenzylguanidine (MIBG) scintigraphy

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

A 31-year-old woman gradually developed weakness in the lower extremities and gait disturbance. Subsequently, the patient developed severe constipation and hypertension with tachycardia. Nerve conduction studies revealed demyelinating polyneuropathy. Serum anti-GQ1b IgG antibody was detected. The levels of plasma noradrenaline and dopamine and urinary noradrenaline were elevated. Cardiac [123I] metaiodobenzylguanidine (MIBG) scintigraphy showed a normal H/M rate at the early phase and an elevated washout rate. According to these findings, the patient was diagnosed with Guillain-Barré syndrome with cardiac sympathetic hyperactivity. During convalescence, the plasma and urine catecholamine levels fell within the reference ranges, and MIBG scintigraphy showed a decreased washout rate.

Cite

CITATION STYLE

APA

Tanaka, Y., & Satomi, K. (2016). Cardiac sympathetic hyperactivity in a patient with Guillain-Barré syndrome: An analysis using cardiac [123I] metaiodobenzylguanidine (MIBG) scintigraphy. Internal Medicine, 55(3), 299–302. https://doi.org/10.2169/internalmedicine.55.3941

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free